Market overview
The global omega-3 supplements market is worth USD 5.5 bn in 2026 and is forecast to reach USD 9.9 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Fish oil is the largest by source segment.
| Scope | Omega-3 dietary supplements for consumers, including fish oil, krill oil, cod liver oil and algal oil capsules, softgels and liquids, sold through retail, pharmacies, direct selling and online. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 5.2 bn |
| Value 2026 | USD 5.5 bn |
| Value 2036 | USD 9.9 bn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 345 million bottles |
| Volume 2036 | 532 million bottles |
| Average price 2026 | USD 16.0 per bottle |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Omega-3 Supplements market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 5.5 bn |
| 2027 | USD 5.8 bn |
| 2028 | USD 6.2 bn |
| 2029 | USD 6.6 bn |
| 2030 | USD 7.0 bn |
| 2031 | USD 7.4 bn |
| 2032 | USD 7.8 bn |
| 2033 | USD 8.3 bn |
| 2034 | USD 8.8 bn |
| 2035 | USD 9.3 bn |
| 2036 | USD 9.9 bn |
Omega-3 Supplements market segmentation
By source
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fish oil | 70.0% | 66.3% | USD 3.9 bn | 5.4% |
| Krill oil | 9.0% | 9.4% | USD 496 mn | 6.4% |
| Algal oil | 11.0% | 16.5% | USD 606 mn | 10.4% |
| Cod liver and other oils | 10.0% | 7.8% | USD 551 mn | 3.4% |
By form
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Softgels and capsules | 74.0% | 68.2% | USD 4.1 bn | 5.1% |
| Liquids | 12.0% | 12.2% | USD 661 mn | 6.1% |
| Gummies and chewables | 14.0% | 19.6% | USD 772 mn | 9.6% |
By distribution channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmacies and retail | 50.0% | 44.4% | USD 2.8 bn | 4.7% |
| Online | 30.0% | 38.7% | USD 1.7 bn | 8.7% |
| Direct selling and other | 20.0% | 16.9% | USD 1.1 bn | 4.2% |
By consumer age
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adults | 52.0% | 48.0% | USD 2.9 bn | 5.2% |
| Seniors | 24.0% | 27.0% | USD 1.3 bn | 7.3% |
| Children and teens | 10.0% | 10.0% | USD 551 mn | 6.0% |
| Pregnant and nursing women | 14.0% | 15.0% | USD 772 mn | 6.7% |
By health claim
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Heart health | 34.0% | 32.0% | USD 1.9 bn | 5.4% |
| Brain and eye health | 26.0% | 28.0% | USD 1.4 bn | 6.8% |
| Joint and inflammation | 20.0% | 20.0% | USD 1.1 bn | 6.0% |
| Prenatal and general wellness | 20.0% | 20.0% | USD 1.1 bn | 6.0% |
Top 25 countries for omega-3 supplements by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.0% of 2026 revenue and the 25 countries below together hold 94.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.7 bn | 30.0% | USD 2.7 bn | 5.0% |
| 2 | China | USD 717 mn | 13.0% | USD 1.7 bn | 8.9% |
| 3 | Japan | USD 386 mn | 7.0% | USD 573 mn | 4.0% |
| 4 | Germany | USD 331 mn | 6.0% | USD 533 mn | 4.9% |
| 5 | Australia | USD 276 mn | 5.0% | USD 444 mn | 4.9% |
| 6 | United Kingdom | USD 276 mn | 5.0% | USD 444 mn | 4.9% |
| 7 | Canada | USD 220 mn | 4.0% | USD 375 mn | 5.5% |
| 8 | France | USD 193 mn | 3.5% | USD 316 mn | 5.0% |
| 9 | South Korea | USD 193 mn | 3.5% | USD 375 mn | 6.9% |
| 10 | India | USD 165 mn | 3.0% | USD 464 mn | 10.9% |
| 11 | Norway | USD 113 mn | 2.0% | USD 201 mn | 6.0% |
| 12 | Netherlands | USD 103 mn | 1.9% | USD 184 mn | 5.9% |
| 13 | Spain | USD 87 mn | 1.6% | USD 156 mn | 6.0% |
| 14 | Italy | USD 80 mn | 1.4% | USD 142 mn | 5.9% |
| 15 | Mexico | USD 68 mn | 1.2% | USD 120 mn | 5.9% |
| 16 | Taiwan | USD 62 mn | 1.1% | USD 111 mn | 6.0% |
| 17 | Brazil | USD 56 mn | 1.0% | USD 101 mn | 6.0% |
| 18 | Malaysia | USD 46 mn | 0.8% | USD 82 mn | 5.9% |
| 19 | Thailand | USD 39 mn | 0.7% | USD 69 mn | 5.8% |
| 20 | Switzerland | USD 34 mn | 0.6% | USD 61 mn | 6.0% |
| 21 | New Zealand | USD 33 mn | 0.6% | USD 58 mn | 6.0% |
| 22 | Sweden | USD 30 mn | 0.5% | USD 53 mn | 6.0% |
| 23 | Denmark | USD 24 mn | 0.4% | USD 43 mn | 6.0% |
| 24 | Chile | USD 22 mn | 0.4% | USD 39 mn | 6.0% |
| 25 | Peru | USD 19 mn | 0.3% | USD 34 mn | 6.0% |
| Rest of world | USD 287 mn | 5.2% | USD 519 mn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Nature's Bounty
- Pharmavite
- Haleon
- Amway
- GNC
- Herbalife
Group 2: Regional and specialist players
- Nordic Naturals
- Blackmores
- Orkla Health
- Carlson Laboratories
- Minami Nutrition
- Pharma Nord
- Barlean's
- Solgar
- Swisse Wellness
Group 3: Emerging and niche players
- Ritual
- Thorne
- Care/of
- Zinzino
- Wiley's Finest
- Sports Research
- Viva Naturals
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the omega-3 supplements market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by source, by form, by distribution channel, by consumer age, by health claim. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the omega-3 supplements market?
The global omega-3 supplements market is estimated at USD 5.2 bn in 2025 and USD 5.5 bn in 2026.
How fast will the omega-3 supplements market grow?
It is forecast to reach USD 9.9 bn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 4.4 bn.
Which country is the largest market for omega-3 supplements?
United States is the largest market by revenue at USD 1.7 bn in 2026, 30.0% of the global total. The three largest countries together hold 50.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.9% a year from 2026 to 2036.
Which omega-3 supplements segment is largest?
In the by source split, Fish oil is the largest segment with 70.0% of 2026 revenue.
Who are the leading omega-3 supplements companies?
Global leaders include Nature's Bounty, Pharmavite, Haleon, Amway.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Sterile Single-Use Endoscopy AccessoriesUSD 5.4 bn · 7.5% CAGR
- Clinical Trial SupplyUSD 5.7 bn · 9.0% CAGR
- Track and TraceUSD 5.7 bn · 9.5% CAGR
- Flow CytometryUSD 5.7 bn · 7.5% CAGR
- Patient RecruitmentUSD 5.2 bn · 9.0% CAGR
- LiposomeUSD 5.2 bn · 8.0% CAGR
- Cleanroom EquipmentUSD 6.0 bn · 8.0% CAGR
- Microsphere Drug DeliveryUSD 6.0 bn · 8.0% CAGR
← Oligonucleotide Therapeutics Oncology Biomarker Translation Services →